- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00201552
Statin and PAF in Patients With Pacemaker
September 19, 2005 updated by: National Taiwan University Hospital
Atorvastatin Decreases Atrial Fibrillation Burden in Patients With Paroxysmal Atrial Fibrillation
Statin could decrease AF burden
Study Overview
Detailed Description
Statin could decrease AF burden in patients with PAF.
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Chia-Ti Tsai, MD
- Phone Number: 5761 886-2-23123456
- Email: fang31@ms39.hinet.net
Study Locations
-
-
-
Taipei, Taiwan
- Recruiting
- National Taiwan University Hospital
-
Contact:
- Chia-Ti Tsai
-
Principal Investigator:
- Chia-Ti Tsai, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients with pacemaker
Exclusion Criteria:
- Patients with hepatic dysfunction
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Jiunn-Lee Lin, MD, PhD, National Taiwan University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates
First Submitted
September 12, 2005
First Submitted That Met QC Criteria
September 19, 2005
First Posted (Estimate)
September 20, 2005
Study Record Updates
Last Update Posted (Estimate)
September 20, 2005
Last Update Submitted That Met QC Criteria
September 19, 2005
Last Verified
September 1, 2005
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 930106
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Paroxysmal Atrial Fibrillation
-
Medtronic Cardiac Rhythm and Heart FailureCompletedParoxysmal Atrial Fibrillation (PAF)United States, Canada
-
Biosense Webster, Inc.Active, not recruitingRefractory Paroxysmal Atrial FibrillationChina
-
Boston Scientific CorporationCompletedParoxysmal Atrial Fibrillation (PAF)United States, Spain, Germany, Australia, United Kingdom, Sweden, Czechia, France, Portugal
-
Charite University, Berlin, GermanyGerman Federal Ministry of Education and ResearchTerminatedSymptomatic Paroxysmal Atrial FibrillationGermany
-
Biosense Webster, Inc.RecruitingDrug Refractory Paroxysmal Atrial FibrillationUnited States
-
Hospital Clinic of BarcelonaCompletedDrug-refractory Paroxysmal Atrial FibrillationSpain
-
Ablacon, Inc.RecruitingAtrial Fibrillation | Arrhythmias, Cardiac | Arrhythmia | Atrial Flutter | Atrial Fibrillation, Persistent | Atrial Tachycardia | Atrial Arrhythmia | Atrial Fibrillation Paroxysmal | Atrial Fibrillation, Paroxysmal or PersistentUnited States, Belgium, Netherlands, Czechia
-
Biosense Webster, Inc.CompletedDrug Refractory Symptomatic Paroxysmal Atrial FibrillationUnited States
-
Medtronic Cardiac Rhythm and Heart FailureMedtronic Atrial Fibrillation SolutionsCompletedSymptomatic Paroxysmal Atrial Fibrillation Without Clinically Significant Heart DiseasesNetherlands, Australia, France, Norway, Germany, Croatia, Italy, Argentina, Belgium
-
Beijing Anzhen HospitalJohnson & Johnson; Heart Health Research CenterNot yet recruitingParoxysmal Atrial Fibrillation | Persistent Atrial Fibrillation
Clinical Trials on Statin
-
Organon and CoMerck Sharp & Dohme LLCCompletedHypercholesterolemia | Coronary Heart Disease | Hyperlipidemia
-
Antalya Training and Research HospitalCompleted
-
National Taiwan University HospitalCompletedOut-Of-Hospital Cardiac ArrestTaiwan
-
Faculty of Medicine, Tarumanagara UniversityCengkareng General HospitalCompletedAcute Coronary Syndrome | Cardiogenic Shock | Recurrent Myocardial InfarctionIndonesia
-
Taipei Medical University WanFang HospitalTerminated
-
University of Sao Paulo General HospitalUnknownAneurysmal Subarachnoid HemorrhageBrazil
-
Radboud University Medical CenterErasmus Medical Center; Academisch Medisch Centrum - Universiteit van Amsterdam...Completed
-
Translational Research Center for Medical Innovation...National Cerebral and Cardiovascular Center; Ministry of Health, Labour and... and other collaboratorsCompleted
-
Capital Medical UniversityRecruitingIntracerebral Hemorrhage | StatinsChina
-
University of LiverpoolUniversity of Leeds; Liverpool John Moores University; Liverpool Heart and Chest... and other collaboratorsTerminatedAtrial Fibrillation | Chronic Kidney DiseaseUnited Kingdom